Trieu Vuong bought OTLC
July 1, 2026 · Form 4 insider transaction
Trieu Vuong bought 240,000 shares of Oncotelic Therapeutics, Inc. at $0.04 per share, a transaction worth $10.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
240,000
Price
$0.04
Total value
$10.3K
InsiderTrieu Vuong
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJuly 1, 2026
Filing dateJuly 2, 2026
Shares owned after94,124,319
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On July 1, 2026, Dr. Vuong Trieu purchased 240,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.0431.